NCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
Fox Chase Cancer Center
Rutgers, The State University of New Jersey
Indiana University
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute